Pacira Pharmaceuticals, Inc. logo

PCRX

Pacira Pharmaceuticals, Inc.

$26.83

Earnings Summary

Revenue
$181.24Mn
Net Profits
$24.87Mn
Net Profit Margins
13.72%
PE Ratio
31.27

Highlights

Revenue:

Pacira Pharmaceuticals, Inc.’s revenue jumped 5.4% since last year same period to $181.24Mn in the Q4 2023. On a quarterly growth basis, Pacira Pharmaceuticals, Inc. has generated 10.56% jump in its revenue since last 3-months.

Net Profits:

Pacira Pharmaceuticals, Inc.’s net profit jumped 346.19% since last year same period to $24.87Mn in the Q4 2023. On a quarterly growth basis, Pacira Pharmaceuticals, Inc. has generated 129.05% jump in its net profits since last 3-months.

Net Profit Margins:

Pacira Pharmaceuticals, Inc.’s net profit margin jumped 333.57% since last year same period to 13.72% in the Q4 2023. On a quarterly growth basis, Pacira Pharmaceuticals, Inc. has generated 107.16% jump in its net profit margins since last 3-months.

PE Ratio:

Pacira Pharmaceuticals, Inc.’s price-to-earnings ratio after this Q4 2023 earnings stands at 31.27.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Pacira Pharmaceuticals, Inc. post its latest quarter earnings

EPS Estimate Current Quarter
0.63
EPS Estimate Current Year
0.63

Highlights

EPS Estimate Current Quarter:

Pacira Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.63 - a -28.41% fall from last quarter’s estimates.

EPS Estimate Current Year:

Pacira Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current year stand at 0.63.

Key Ratios

Key ratios of the Pacira Pharmaceuticals, Inc. post its Q4 2023 earnings

Earning Per Share (EPS)
0.89
Return on Assets (ROA)
0.03
Return on Equity (ROE)
0.05

Highlights

Earning Per Share (EPS):

Pacira Pharmaceuticals, Inc.’s earning per share (EPS) jumped 11.25% since last year same period to 0.89 in the Q4 2023. This indicates that the Pacira Pharmaceuticals, Inc. has generated 11.25% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Pacira Pharmaceuticals, Inc.’s return on assets (ROA) stands at 0.03.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Pacira Pharmaceuticals, Inc.’s return on equity (ROE) stands at 0.05.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-02-29
0.88
0.89
1.14%
2023-08-02
0.76
0.78
2.63%
2023-05-03
0.62
0.53
-14.52%
2023-11-02
0.78
0.72
-7.69%